| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 09/21/2011 | CN101181503B Chinese medicine prescription orally taken for curing chronic bronchitis |
| 09/21/2011 | CN101166534B Therapeutic agent for chronic obstructive pulmonary disease |
| 09/21/2011 | CN101091745B Decoction medicine for treating chronic one-way rhinitis, and preparation method |
| 09/20/2011 | US8022041 Prodrug of an ICE inhibitor |
| 09/20/2011 | US8021838 Transcriptional regulation of target genes |
| 09/20/2011 | US8021693 Methods of organ regeneration using Hox11-expressing pluripotent cells |
| 09/20/2011 | US8021687 Modified release compositions of milnacipran |
| 09/20/2011 | CA2589146C Process for producing muscarine receptor antagonist and intermediate therefor |
| 09/20/2011 | CA2548668C Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 09/20/2011 | CA2493483C Endiandric acid h as c-maf inhibitors derivatives for use against asthma |
| 09/20/2011 | CA2482637C New esters of hydroxy-substituted nitrogen heterocycles as antagonists of the muscarinic m3 receptor, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions |
| 09/20/2011 | CA2473686C Novel cytokine zcytor17 ligand |
| 09/20/2011 | CA2471578C Xanthene-carboxylic acid esters of tropenol and scopine as m3 antagonists, method for producing the same and use thereof as medicaments |
| 09/20/2011 | CA2462903C Beta-lactamyl vasopressin v1a antagonists |
| 09/20/2011 | CA2455966C Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 09/20/2011 | CA2453817C Organophosphorus compounds for the activation of gamma/delta t-cells |
| 09/20/2011 | CA2411726C Use of ingenanes in treating a pkc-related condition or disorder |
| 09/20/2011 | CA2377977C Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes |
| 09/20/2011 | CA2376485C Recombinant anti-cd40 antibody and uses thereof |
| 09/20/2011 | CA2347248C Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 09/15/2011 | WO2011112995A1 Imidazopyridines syk inhibitors |
| 09/15/2011 | WO2011112983A2 Psrp is a protective antigen against pneumococcal infection |
| 09/15/2011 | WO2011112766A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 09/15/2011 | WO2011111714A1 Novel ep4 agonist |
| 09/15/2011 | WO2011111707A1 Allergy inhibitor |
| 09/15/2011 | WO2011110859A1 Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd |
| 09/15/2011 | WO2011110858A1 Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd |
| 09/15/2011 | WO2011110824A1 Bis aromatic compounds for use as ltc4 synthase inhibitors |
| 09/15/2011 | WO2011110575A1 Derivatives of 2-[2-(benzo- or pyrido-) thiazolylamino]-6-aminopyridine, useful in the treatment of respiratoric, allergic or inflammatory diseases |
| 09/15/2011 | WO2011110183A1 Azaisoquinolinone derivatives as nk3 antagonists |
| 09/15/2011 | WO2011037550A3 Dry powder combination of tiotropium |
| 09/15/2011 | US20110224406 Interleukin-9 receptor mutants |
| 09/15/2011 | US20110224283 Antisense modulation of nuclear hormone receptors |
| 09/15/2011 | US20110224265 Gel containing pirfenidone |
| 09/15/2011 | US20110224262 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 09/15/2011 | US20110224251 Therapeutic Pyrazolyl Thienopyridines |
| 09/15/2011 | US20110224250 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient |
| 09/15/2011 | US20110224247 Azaisoquinolinone derivatives as nk3 antagonists |
| 09/15/2011 | US20110224229 Novel Crystalline Form |
| 09/15/2011 | US20110224217 Methods of treatment using heteroaryl compounds and compositions thereof |
| 09/15/2011 | US20110224209 4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl peptidase-1 (dpp-1) |
| 09/15/2011 | US20110224196 Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent |
| 09/15/2011 | US20110224188 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-alpha]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES |
| 09/15/2011 | US20110224187 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof |
| 09/15/2011 | US20110224177 Combinations comprising antimuscarinic agents and corticosteroids |
| 09/15/2011 | US20110224172 Substituted 1-Oxa-2,8-Diaza-Spiro [4,5] Dec-2-Ene Derivatives and Related Treatment Methods |
| 09/15/2011 | US20110224153 Asthma Associated Factors as Targets for Treating Atopic Allergies Including Asthma and Related Disorders |
| 09/15/2011 | US20110224132 Use of the long pentraxin ptx3 for the prevention or treatment of viral diseases |
| 09/15/2011 | US20110223621 Combinations for the treatment of immunoinflammatory disorders |
| 09/15/2011 | US20110223249 Extended release compositions comprising mycophenolate sodium and processes thereof |
| 09/15/2011 | US20110223216 Nanoparticles and Porous Particles and Methods of Making the Same |
| 09/15/2011 | US20110223203 Nanocluster compositions and methods |
| 09/15/2011 | US20110223168 Ligand that has binding specificity for il-4 and/or il-13 |
| 09/15/2011 | US20110223130 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE |
| 09/15/2011 | US20110223113 Propellant for dosing aerosols comprising packagings |
| 09/15/2011 | US20110220265 Preparation for External Use |
| 09/15/2011 | CA2792769A1 Imidazopyridines syk inhibitors |
| 09/15/2011 | CA2792727A1 Therapy for influenza like illness |
| 09/15/2011 | CA2792726A1 Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd |
| 09/15/2011 | CA2792725A1 Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd |
| 09/15/2011 | CA2792403A1 Novel ep4 agonist |
| 09/15/2011 | CA2791417A1 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 09/14/2011 | EP2364997A2 Polypeptide variants with altered effector function |
| 09/14/2011 | EP2364982A1 Spiro-piperidine compounds as chemokine receptor antagonists and medicinal use thereof |
| 09/14/2011 | EP2364731A2 Methods of administering anti-TNFalpha antibodies |
| 09/14/2011 | EP2364708A2 Pharmaceutical composition comprising a C1C-2 channel opener |
| 09/14/2011 | EP2364327A1 Binding members against il-1r1 |
| 09/14/2011 | EP2364316A1 6, 7 -dihydro- 5h- pyrrolo [3, 4-d¨pyrimidin-4-yl]-quinolin-3 -ylamine compounds useful as FAAH modulators and uses thereof |
| 09/14/2011 | EP2364088A1 Bicyclic aryl sphingosine 1-phosphate analogs |
| 09/14/2011 | EP1904054B1 Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity |
| 09/14/2011 | EP1871374B1 2,3 substituted pyrazine sulfonamides as inhibitors of crth2 |
| 09/14/2011 | EP1713480B1 The use of quaternary pyridinium salts as vasoprotective agents |
| 09/14/2011 | EP1559716B1 Pyrazolonaphthyridine derivative |
| 09/14/2011 | EP1534277B1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 09/14/2011 | EP1471915B1 2,4-pyrimidinediamine compounds and their uses |
| 09/14/2011 | EP1346982B1 Vla-4 inhibitors |
| 09/14/2011 | CN1918146B Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 09/14/2011 | CN1642551B Inhibitors of histone deacetylase |
| 09/14/2011 | CN1561345B Antibodies to VLA-1 |
| 09/14/2011 | CN102186850A Phenanthroindolizidine derivative and nfkb inhibitor containing same as active ingredient |
| 09/14/2011 | CN102186849A Phenanthroindolizidine compound and nf?b inhibitor containing same as active ingredient |
| 09/14/2011 | CN102186845A S1p receptors modulators and their use thereof |
| 09/14/2011 | CN102186839A Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 09/14/2011 | CN102186838A Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 09/14/2011 | CN102186818A 7-(piperazine-1-ymethyl)-1h-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 map kinase inhibitors for the treatment of respiratory diseases |
| 09/14/2011 | CN102186481A Methods of treating pulmonary disorders with liposomal amikacin formulations |
| 09/14/2011 | CN102186458A Method for treatment of copd and other pulmonary diseases |
| 09/14/2011 | CN102180890A Cefathiamidine hydrate and preparation method and application thereof |
| 09/14/2011 | CN102180889A Ceftizoxime sodium crystalline hydrate and preparation method and application thereof |
| 09/14/2011 | CN102178957A Respiratory tract homing siRNA atomizing nanometer drug delivery system and preparation method thereof |
| 09/14/2011 | CN102178956A Preparation, medical application and composition of 20S-protopanaxadiol beta-cyclodextrin inclusion compound |
| 09/14/2011 | CN102178953A Interleukin-17F antibodies and other IL-17F signaling antagonists and uses therefor |
| 09/14/2011 | CN102178931A Recombinant human interleukin-12 preparation for injection and preparation method thereof |
| 09/14/2011 | CN102178921A Medicament for treating cough in children |
| 09/14/2011 | CN102178905A Chinese medicine body surface application therapeutic technology and Chinese medicine combinations |
| 09/14/2011 | CN102178888A Medicament for treating female language dysfunction |
| 09/14/2011 | CN102178881A Drug for treating short breath |
| 09/14/2011 | CN102178865A Chinese medicinal herbal composition for treating nasosinusitis |
| 09/14/2011 | CN102178864A Chinese medicinal oral liquid for treating amygdalitis |
| 09/14/2011 | CN102178848A Traditional Chinese medicinal dendrobium officinale preparation and preparation method thereof |